Skip to content

Clinical Comparison of Two Silicone Hydrogel Toric Lenses in the US

Clinical Comparison of Two Silicone Hydrogel Toric Lenses in the US

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01007812
Enrollment
50
Registered
2009-11-04
Start date
2009-10-31
Completion date
2009-11-30
Last updated
2012-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Astigmatism

Brief summary

The purpose of this trial is to compare the performance of two different contact lenses for contact lens wearers with astigmatism.

Interventions

Silicone hydrogel, toric, soft contact lens

Silicone hydrogel, toric, soft contact lens

Sponsors

CIBA VISION
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Have a current spectacle prescription, preferably within 6-9 months. * Currently wearing toric soft contact lenses in both eyes with at least 1 month experience wearing current brand for daily wear. * Be correctable to at least 20/40 distance visual acuity in each eye while wearing trial lenses in the parameters available for this trial. * Have acceptable or optimal fit for each eye at the dispense of each pair of study lenses. * Other protocol-defined inclusion/

Exclusion criteria

may apply.

Design outcomes

Primary

MeasureTime frameDescription
Overall VisionAfter 1 week of wearOverall vision, as interpreted by the subject and reported by the subject on a questionnaire as a single, retrospective evaluation of one week's wear time. Overall vision was measured on a 10-point scale, with 1 being poor and 10 being excellent.

Participant flow

Participants by arm

ArmCount
Overall Study
This reporting group includes all enrolled and dispensed subjects.
50
Total50

Withdrawals & dropouts

PeriodReasonFG000FG001
Period 1, One WeekDiscomfort10
Period 1, One WeekLost to Follow-up01

Baseline characteristics

CharacteristicOverall Study
Age Continuous33.4 years
STANDARD_DEVIATION 11.2
Sex: Female, Male
Female
33 Participants
Sex: Female, Male
Male
17 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 490 / 49
serious
Total, serious adverse events
0 / 490 / 49

Outcome results

Primary

Overall Vision

Overall vision, as interpreted by the subject and reported by the subject on a questionnaire as a single, retrospective evaluation of one week's wear time. Overall vision was measured on a 10-point scale, with 1 being poor and 10 being excellent.

Time frame: After 1 week of wear

Population: Per Protocol

ArmMeasureValue (MEAN)Dispersion
Lotrafilcon B Contact LensOverall Vision8.2 Units on a ScaleStandard Deviation 1.8
Comfilcon A Contact LensOverall Vision8.3 Units on a ScaleStandard Deviation 1.8

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026